Amersham Biosciences.Amersham Biosciences reported a 3.3% increase in third quarter revenues of o156.0 million ($240.0 million = 0.65 [pounds sterling] = $1) compared to revenues of 151.0 million [pounds sterling] ($215.7 million = 0.70 [pounds sterling] = $1). Discovery Systems posted "modest growth," but sales of reagents and consumables were good. Sales of Protein Separations systems increased 13% and are expected to accelerate over the fourth quarter. Amersham plc Amersham plc was a UK pharmaceutical company, specializing in medical diagnostics and life science products. The company was formed in 1997 by merging Amersham International (U.K.), Pharmacia Biotech (Sweden) and Nycomed (Norway). stated that year-end year-end also year·end n. The end of a year. adj. Occurring or done at the end of the year: a year-end audit. Noun 1. revenue estimates are expected to meet previous targets of 1.7 billion [pounds sterling].
hird Quarter Ended Sept. 30th
2002 2001 %
([pounds sterling] GBP M) 3Q 3Q chg.
Rev. 156.0 151.0 3.3%
Op. Profit 15.3 14.3 7.0%
|
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion